Good morning :)
Place Order
Add to Watchlist

J B Chemicals and Pharmaceuticals Ltd

JBCHEPHARM

J B Chemicals and Pharmaceuticals Ltd

JBCHEPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹28,052 cr, stock is ranked 274
Moderate RiskStock is 2.45x as volatile as Nifty
1,800.100.40% (-7.25)
1,800.100.40% (-7.25)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹28,052 cr, stock is ranked 274
Moderate RiskStock is 2.45x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹28,052 cr, stock is ranked 274
Moderate RiskStock is 2.45x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
50.7611.310.68%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
45.256.090.56%

Forecast & Ratings

Detailed Forecast 
85%
Analysts have suggested that investors can buy this stock

from 13 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs).

Investor Presentation

View older 

Aug 9, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 15.89%, vs industry avg of 8.96%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.74% to 0.96%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 23.36%, vs industry avg of 15.15%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue1,268.431,394.451,445.491,684.641,825.402,154.902,463.473,159.223,521.453,521.45
Raw Materialssubtract483.71519.54544.41615.76634.79742.76860.381,179.202,587.292,587.29
Power & Fuel Costsubtract55.2854.8958.2863.2961.5462.6071.4791.54
Employee Costsubtract175.31217.34251.10288.18322.92340.60439.24543.45
Selling & Administrative Expensessubtract157.42174.28205.31234.51228.72233.56358.90448.81
Operating & Other expensessubtract132.62145.85131.98135.62159.19102.59150.79190.53
Depreciation/Amortizationsubtract41.2247.2256.9755.6466.3268.6772.66114.41138.32138.32
Interest & Other Itemssubtract10.655.373.494.653.037.245.1236.0544.3344.33
Taxes & Other Itemssubtract49.6845.8855.6193.5276.85148.92119.54145.40198.88198.87
EPS9.5810.858.2211.8117.2728.9824.9326.5035.6635.71
DPS2.500.501.002.505.508.258.258.8812.2510.13
Payout ratio0.260.050.120.210.320.280.330.330.340.28

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 27PDF
Feb 14PDF
Jan 27PDF
Nov 11PDF
FY 2023

Annual report

PDF

Investor Presentation

May 24PDF
Feb 8PDF
Jan 10PDF
+2 more
FY 2024

Annual Report Pending

Investor Presentation

Aug 9PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
J B Chemicals and Pharmaceuticals Ltd50.7611.310.68%
Sun Pharmaceutical Industries Ltd39.945.700.85%
Cipla Ltd29.525.130.86%
Zydus Lifesciences Ltd30.915.400.25%

Price Comparison

Compare JBCHEPHARM with any stock or ETF
Compare JBCHEPHARM with any stock or ETF
JBCHEPHARM
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding53.78%15.45%2.94%11.06%16.78%

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Shareholding History

Dec '22MarJunSepDec '23Mar8.80%8.63%9.54%10.05%10.35%11.06%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding J B Chemicals and Pharmaceuticals Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Axis Small Cap Fund - Growth - Direct Plan

Growth
1.5103%1.90%-0.29%68/132 (-27)
Kotak Emerging Equity Fund - Growth - Direct Plan

Growth
1.4522%0.83%0.55%61/80 (+5)
Franklin India Smaller Companies Fund - Growth - Direct Plan

Growth
0.9062%1.81%-0.26%9/99 (0)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have J B Chemicals and Pharmaceuticals Ltd

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

JBCHEPHARM has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.68%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.76 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateFeb 16, 2024

Interim
Interim | Div/Share: ₹5.50

Dividend/Share

5.50

Ex DateEx Date

Feb 16, 2024

Cash Dividend

Ex DateEx DateAug 17, 2023

Final
Final | Div/Share: ₹9.25

Dividend/Share

9.25

Ex DateEx Date

Aug 17, 2023

Cash Dividend

Ex DateEx DateFeb 17, 2023

Interim
Interim | Div/Share: ₹8.50

Dividend/Share

8.50

Ex DateEx Date

Feb 17, 2023

Cash Dividend

Ex DateEx DateAug 12, 2022

Final
Final | Div/Share: ₹8.00

Dividend/Share

8.00

Ex DateEx Date

Aug 12, 2022

Cash Dividend

Ex DateEx DateFeb 23, 2022

Interim
Interim | Div/Share: ₹8.50

Dividend/Share

8.50

Ex DateEx Date

Feb 23, 2022